These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 32508939)
1. Towards definitive management of allergic rhinitis: best use of new and established therapies. Hossenbaccus L; Linton S; Garvey S; Ellis AK Allergy Asthma Clin Immunol; 2020; 16():39. PubMed ID: 32508939 [TBL] [Abstract][Full Text] [Related]
2. Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma. Brunton S; Nelson HS; Bernstein DI; Lawton S; Lu S; Nolte H Postgrad Med; 2017 Aug; 129(6):581-589. PubMed ID: 28326908 [TBL] [Abstract][Full Text] [Related]
3. Focused allergic rhinitis practice parameter for Canada. Ellis AK; Cook V; Keith PK; Mace SR; Moote W; O'Keefe A; Quirt J; Rosenfield L; Small P; Watson W Allergy Asthma Clin Immunol; 2024 Aug; 20(1):45. PubMed ID: 39118164 [TBL] [Abstract][Full Text] [Related]
6. Effects of H1 antihistamine addition to intranasal corticosteroid for allergic rhinitis: a systematic review and meta-analysis. Seresirikachorn K; Chitsuthipakorn W; Kanjanawasee D; Khattiyawittayakun L; Snidvongs K Int Forum Allergy Rhinol; 2018 Oct; 8(10):1083-1092. PubMed ID: 29917324 [TBL] [Abstract][Full Text] [Related]
7. Specific immunotherapy (SIT) in the treatment of allergic rhinitis. Hagen A; Gorenoi V; Schönermark MP GMS Health Technol Assess; 2010 Mar; 6():Doc01. PubMed ID: 21289874 [TBL] [Abstract][Full Text] [Related]
8. Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma. Vogelberg C; Brüggenjürgen B; Richter H; Jutel M Patient Prefer Adherence; 2020; 14():817-827. PubMed ID: 32494127 [TBL] [Abstract][Full Text] [Related]
9. Combined medical therapy in the treatment of allergic rhinitis: Systematic review and meta-analyses. Chitsuthipakorn W; Hoang MP; Kanjanawasee D; Seresirikachorn K; Snidvongs K Int Forum Allergy Rhinol; 2022 Dec; 12(12):1480-1502. PubMed ID: 35446512 [TBL] [Abstract][Full Text] [Related]
10. Real-world, long-term effectiveness of allergy immunotherapy in allergic rhinitis: Subgroup analyses of the REACT study. Contoli M; Porsbjerg C; Buchs S; Larsen JR; Freemantle N; Fritzsching B J Allergy Clin Immunol; 2023 Aug; 152(2):445-452.e4. PubMed ID: 36871918 [TBL] [Abstract][Full Text] [Related]
11. Intranasal spray medications for maintenance therapy of allergic rhinitis. Berger WE; Meltzer EO Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312 [TBL] [Abstract][Full Text] [Related]
12. State of the Art: Development of a Sublingual Allergy Immunotherapy Tablet for Allergic Rhinitis in Japan. Ohashi-Doi K; Lund K; Mitobe Y; Okamiya K Biol Pharm Bull; 2020; 43(1):41-48. PubMed ID: 31902930 [TBL] [Abstract][Full Text] [Related]
13. Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost. Dranitsaris G; Ellis AK J Eval Clin Pract; 2014 Jun; 20(3):225-38. PubMed ID: 24444390 [TBL] [Abstract][Full Text] [Related]
14. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial. Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432 [TBL] [Abstract][Full Text] [Related]
15. Immunotherapy in the Treatment of Allergic Rhinitis in Children. Alamri RA; Aljabri GH; Tahlawi R; Aljabri HA Cureus; 2022 Dec; 14(12):e32464. PubMed ID: 36644088 [TBL] [Abstract][Full Text] [Related]
16. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies. Calderon MA; Casale TB; Nelson HS; Demoly P J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829 [TBL] [Abstract][Full Text] [Related]
17. Efficacy, patients' perception, and cost of medication in allergic rhinitis with subcutaneous immunotherapy. Thanborisutkul K; Khodtecha N; Kulalert P; Sritipsukho P Asian Pac J Allergy Immunol; 2023 Sep; 41(3):199-205. PubMed ID: 32828119 [TBL] [Abstract][Full Text] [Related]
18. [Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 2: Practical aspects of application]. von Bernus L; Högger P; Pfaar O; Klimek L HNO; 2012 Aug; 60(8):700-6. PubMed ID: 22532282 [TBL] [Abstract][Full Text] [Related]
19. The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases. Nolte H; Maloney J Allergol Int; 2018 Jul; 67(3):301-308. PubMed ID: 29759659 [TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of immunotherapy in allergic rhinitis. Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 27658025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]